A research from the MD Anderson Cancer Center says that a genetic signature could predict lung cancer progression. The study authors believe it may help guide medical treatment decisions, provide prognostic information and add biological information about tumors.
Researchers at the MD Anderson Cancer at the University of Texas have identified a genetic signature that may predict progression of lung cancer non-small cell. The work of the researchers has been presented during the conferences at the American Association for Cancer Research and the International Association for the Study of Lung Cancer held in California.
The receiver of the epidermal growth factor receptor (EGFR) is a validated therapeutic target for lung cancer non-small cell. Researchers have now discovered a 93-gene signature that is associated with the presence of EGFR mutations in tumors from lung cancer patients and is a favorable prognostic marker in patients with early stage lung cancer.
Cancer scientists, who conducted this study, hope that it will guide new approaches to lung cancer treatment and help with prognosis.
In the meanwhile consider this. A woman, diagnosed with lung cancer and given only months to live, miraculously survives and is cured by praying Mary and asking her intercession. Kathleen Evans from Australia, 66, was given only months to live. friend, Mrs Evans started praying. Her baffled doctors told her ten months after lung cancer diagnosis that she is cured and her cancer is gone. Mary MacKillop is set to become Australia's first saint.
Written by Armen Hareyan
HULIQ.com
Comment and add to the story without registration, but keep the comments meaningful please. Links are not accepted.
